Location History:
- Ingelheim, DE (2007)
- Setzingen, DE (2008 - 2009)
Company Filing History:
2 out of 1,535 
1 out of 194 
1 out of 306 
Years Active: 2007-2009
Title: Klaus Bornemann: Innovator in Amyloid Beta Peptides Research
Introduction
Klaus Bornemann is a prominent inventor based in Setzingen, Germany, known for his significant contributions to the field of biomedical research. With a portfolio of four patents, he has focused primarily on methodologies related to treating diseases and conditions linked to amyloid beta peptides, which play a critical role in neurodegenerative disorders such as Alzheimer's disease.
Latest Patents
Bornemann's latest patents encompass innovative methods for treating or preventing diseases associated with altered levels of amyloid beta peptides. His cutting-edge approach involves administering therapeutically effective amounts of compounds designed to target increased levels of isoforms of amyloid beta peptides and address the formation of amyloid plaques. These patents not only showcase his inventive capabilities but also highlight the potential impact of his work in therapeutics aimed at improving patient outcomes in neurodegenerative diseases.
Career Highlights
Throughout his career, Klaus Bornemann has collaborated with significant organizations in the pharmaceutical industry, including Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG. His experience in these esteemed companies has provided him with the opportunity to advance his research and develop innovative solutions to complex medical challenges.
Collaborations
During his professional journey, Bornemann worked alongside notable colleagues such as Klaus Klinder and Cornelia Dorner-Ciossek. These collaborations have played a pivotal role in fostering a dynamic research environment, allowing for the exchange of ideas and accelerating the development of novel treatments.
Conclusion
Klaus Bornemann's dedication to advancing the understanding and treatment of conditions related to amyloid beta peptides is commendable. With his extensive work and innovative patents, he continues to make strides in biomedical research, offering hope for effective therapies in the fight against neurodegenerative diseases. The impact of his inventions may not only contribute to scientific knowledge but also significantly benefit patients and healthcare providers alike.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.